Requires physicians to provide a disclosure statement to pregnant women before administering mifepristone for chemical abortion.
This bill mandates that physicians provide a specific disclosure statement to pregnant women before administering mifepristone, a drug used in chemical abortions. The statement informs the patient that the first pill, mifepristone, may not always be effective in ending a pregnancy and advises consulting a physician if the patient regrets their decision. The disclosure must be provided in a manner such as stapling it to the misoprostol package or attaching it to the prescription.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.